 | • レポートコード：GIR-2104Z11453 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、出生前・新生児用遺伝子検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。出生前・新生児用遺伝子検査の種類別市場規模（アレイ比較ゲノムハイブリダイゼーション（aCGH）、蛍光in-situハイブリダイゼーション（FISH）、ポリメラーゼ連鎖反応（PCR））、用途別市場規模（病院、診断機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・出生前・新生児用遺伝子検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Diagnostic、Elitech Group、Myriad Genetics、Biocartis、IntegraGen、Perkin Elmer、WaferGen Biosystem、Interpace Diagnostics、Quest Diagnostic、Bio-Rad、AutoGenomics、Abbott、Cepheid、EKF Diagnostics、Natera、Agilent Technologies、Illumina、Ariosa Diagnostics、Sequenom ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アレイ比較ゲノムハイブリダイゼーション（aCGH）、蛍光in-situハイブリダイゼーション（FISH）、ポリメラーゼ連鎖反応（PCR） ・用途別分析2016年-2026年：病院、診断機関、その他 ・出生前・新生児用遺伝子検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・出生前・新生児用遺伝子検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・出生前・新生児用遺伝子検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・出生前・新生児用遺伝子検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・出生前・新生児用遺伝子検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prenatal and Newborn Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prenatal and Newborn Genetic Testing size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Prenatal and Newborn Genetic Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prenatal and Newborn Genetic Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Array-Comparative Genetic Hybridization (aCGH)
Fluorescence In-Situ Hybridization (FISH)
Polymerase Chain Reaction (PCR)
Market segment by Application, can be divided into
Hospitals
Diagnostic Organization
Other
Market segment by players, this report covers
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Prenatal and Newborn Genetic Testing
1.2 Classification of Prenatal and Newborn Genetic Testing by Type
1.2.1 Overview: Global Prenatal and Newborn Genetic Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type in 2020
1.2.3 Array-Comparative Genetic Hybridization (aCGH)
1.2.4 Fluorescence In-Situ Hybridization (FISH)
1.2.5 Polymerase Chain Reaction (PCR)
1.3 Global Prenatal and Newborn Genetic Testing Market by Application
1.3.1 Overview: Global Prenatal and Newborn Genetic Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Diagnostic Organization
1.3.4 Other
1.4 Global Prenatal and Newborn Genetic Testing Market Size & Forecast
1.5 Global Prenatal and Newborn Genetic Testing Market Size and Forecast by Region
1.5.1 Global Prenatal and Newborn Genetic Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prenatal and Newborn Genetic Testing Market Size by Region, (2016-2021)
1.5.3 North America Prenatal and Newborn Genetic Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Prenatal and Newborn Genetic Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size and Prospect (2016-2026)
1.5.6 South America Prenatal and Newborn Genetic Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prenatal and Newborn Genetic Testing Market Drivers
1.6.2 Prenatal and Newborn Genetic Testing Market Restraints
1.6.3 Prenatal and Newborn Genetic Testing Trends Analysis
2 Company Profiles
2.1 Roche Diagnostic
2.1.1 Roche Diagnostic Details
2.1.2 Roche Diagnostic Major Business
2.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
2.1.4 Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Diagnostic Recent Developments and Future Plans
2.2 Elitech Group
2.2.1 Elitech Group Details
2.2.2 Elitech Group Major Business
2.2.3 Elitech Group Prenatal and Newborn Genetic Testing Product and Solutions
2.2.4 Elitech Group Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Elitech Group Recent Developments and Future Plans
2.3 Myriad Genetics
2.3.1 Myriad Genetics Details
2.3.2 Myriad Genetics Major Business
2.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Product and Solutions
2.3.4 Myriad Genetics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Myriad Genetics Recent Developments and Future Plans
2.4 Biocartis
2.4.1 Biocartis Details
2.4.2 Biocartis Major Business
2.4.3 Biocartis Prenatal and Newborn Genetic Testing Product and Solutions
2.4.4 Biocartis Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Biocartis Recent Developments and Future Plans
2.5 IntegraGen
2.5.1 IntegraGen Details
2.5.2 IntegraGen Major Business
2.5.3 IntegraGen Prenatal and Newborn Genetic Testing Product and Solutions
2.5.4 IntegraGen Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 IntegraGen Recent Developments and Future Plans
2.6 Perkin Elmer
2.6.1 Perkin Elmer Details
2.6.2 Perkin Elmer Major Business
2.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Product and Solutions
2.6.4 Perkin Elmer Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Perkin Elmer Recent Developments and Future Plans
2.7 WaferGen Biosystem
2.7.1 WaferGen Biosystem Details
2.7.2 WaferGen Biosystem Major Business
2.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Product and Solutions
2.7.4 WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 WaferGen Biosystem Recent Developments and Future Plans
2.8 Interpace Diagnostics
2.8.1 Interpace Diagnostics Details
2.8.2 Interpace Diagnostics Major Business
2.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
2.8.4 Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Interpace Diagnostics Recent Developments and Future Plans
2.9 Quest Diagnostic
2.9.1 Quest Diagnostic Details
2.9.2 Quest Diagnostic Major Business
2.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
2.9.4 Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Quest Diagnostic Recent Developments and Future Plans
2.10 Bio-Rad
2.10.1 Bio-Rad Details
2.10.2 Bio-Rad Major Business
2.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Product and Solutions
2.10.4 Bio-Rad Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bio-Rad Recent Developments and Future Plans
2.11 AutoGenomics
2.11.1 AutoGenomics Details
2.11.2 AutoGenomics Major Business
2.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Product and Solutions
2.11.4 AutoGenomics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 AutoGenomics Recent Developments and Future Plans
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Prenatal and Newborn Genetic Testing Product and Solutions
2.12.4 Abbott Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Abbott Recent Developments and Future Plans
2.13 Cepheid
2.13.1 Cepheid Details
2.13.2 Cepheid Major Business
2.13.3 Cepheid Prenatal and Newborn Genetic Testing Product and Solutions
2.13.4 Cepheid Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Cepheid Recent Developments and Future Plans
2.14 EKF Diagnostics
2.14.1 EKF Diagnostics Details
2.14.2 EKF Diagnostics Major Business
2.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
2.14.4 EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 EKF Diagnostics Recent Developments and Future Plans
2.15 Natera
2.15.1 Natera Details
2.15.2 Natera Major Business
2.15.3 Natera Prenatal and Newborn Genetic Testing Product and Solutions
2.15.4 Natera Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Natera Recent Developments and Future Plans
2.16 Agilent Technologies
2.16.1 Agilent Technologies Details
2.16.2 Agilent Technologies Major Business
2.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Product and Solutions
2.16.4 Agilent Technologies Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Agilent Technologies Recent Developments and Future Plans
2.17 Illumina
2.17.1 Illumina Details
2.17.2 Illumina Major Business
2.17.3 Illumina Prenatal and Newborn Genetic Testing Product and Solutions
2.17.4 Illumina Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Illumina Recent Developments and Future Plans
2.18 Ariosa Diagnostics
2.18.1 Ariosa Diagnostics Details
2.18.2 Ariosa Diagnostics Major Business
2.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
2.18.4 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Ariosa Diagnostics Recent Developments and Future Plans
2.19 Sequenom
2.19.1 Sequenom Details
2.19.2 Sequenom Major Business
2.19.3 Sequenom Prenatal and Newborn Genetic Testing Product and Solutions
2.19.4 Sequenom Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Sequenom Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prenatal and Newborn Genetic Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Prenatal and Newborn Genetic Testing Players Market Share
3.2.2 Top 10 Prenatal and Newborn Genetic Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Prenatal and Newborn Genetic Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prenatal and Newborn Genetic Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Prenatal and Newborn Genetic Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Application (2016-2021)
5.2 Prenatal and Newborn Genetic Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prenatal and Newborn Genetic Testing Revenue by Type (2016-2026)
6.2 North America Prenatal and Newborn Genetic Testing Revenue by Application (2016-2026)
6.3 North America Prenatal and Newborn Genetic Testing Market Size by Country
6.3.1 North America Prenatal and Newborn Genetic Testing Revenue by Country (2016-2026)
6.3.2 United States Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prenatal and Newborn Genetic Testing Revenue by Type (2016-2026)
7.2 Europe Prenatal and Newborn Genetic Testing Revenue by Application (2016-2026)
7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Country
7.3.1 Europe Prenatal and Newborn Genetic Testing Revenue by Country (2016-2026)
7.3.2 Germany Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
7.3.3 France Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Region (2016-2026)
8.3.2 China Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
8.3.5 India Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prenatal and Newborn Genetic Testing Revenue by Type (2016-2026)
9.2 South America Prenatal and Newborn Genetic Testing Revenue by Application (2016-2026)
9.3 South America Prenatal and Newborn Genetic Testing Market Size by Country
9.3.1 South America Prenatal and Newborn Genetic Testing Revenue by Country (2016-2026)
9.3.2 Brazil Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Country (2016-2026)
10.3.2 Turkey Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Prenatal and Newborn Genetic Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prenatal and Newborn Genetic Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prenatal and Newborn Genetic Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prenatal and Newborn Genetic Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prenatal and Newborn Genetic Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Region (2021-2026)
Table 6. Roche Diagnostic Corporate Information, Head Office, and Major Competitors
Table 7. Roche Diagnostic Major Business
Table 8. Roche Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
Table 9. Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Elitech Group Corporate Information, Head Office, and Major Competitors
Table 11. Elitech Group Major Business
Table 12. Elitech Group Prenatal and Newborn Genetic Testing Product and Solutions
Table 13. Elitech Group Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 15. Myriad Genetics Major Business
Table 16. Myriad Genetics Prenatal and Newborn Genetic Testing Product and Solutions
Table 17. Myriad Genetics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Biocartis Corporate Information, Head Office, and Major Competitors
Table 19. Biocartis Major Business
Table 20. Biocartis Prenatal and Newborn Genetic Testing Product and Solutions
Table 21. Biocartis Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. IntegraGen Corporate Information, Head Office, and Major Competitors
Table 23. IntegraGen Major Business
Table 24. IntegraGen Prenatal and Newborn Genetic Testing Product and Solutions
Table 25. IntegraGen Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Perkin Elmer Corporate Information, Head Office, and Major Competitors
Table 27. Perkin Elmer Major Business
Table 28. Perkin Elmer Prenatal and Newborn Genetic Testing Product and Solutions
Table 29. Perkin Elmer Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. WaferGen Biosystem Corporate Information, Head Office, and Major Competitors
Table 31. WaferGen Biosystem Major Business
Table 32. WaferGen Biosystem Prenatal and Newborn Genetic Testing Product and Solutions
Table 33. WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Interpace Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. Interpace Diagnostics Major Business
Table 36. Interpace Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
Table 37. Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Quest Diagnostic Corporate Information, Head Office, and Major Competitors
Table 39. Quest Diagnostic Major Business
Table 40. Quest Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
Table 41. Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 43. Bio-Rad Major Business
Table 44. Bio-Rad Prenatal and Newborn Genetic Testing Product and Solutions
Table 45. Bio-Rad Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. AutoGenomics Corporate Information, Head Office, and Major Competitors
Table 47. AutoGenomics Major Business
Table 48. AutoGenomics Prenatal and Newborn Genetic Testing Product and Solutions
Table 49. AutoGenomics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Abbott Corporate Information, Head Office, and Major Competitors
Table 51. Abbott Major Business
Table 52. Abbott Prenatal and Newborn Genetic Testing Product and Solutions
Table 53. Abbott Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Cepheid Corporate Information, Head Office, and Major Competitors
Table 55. Cepheid Major Business
Table 56. Cepheid Prenatal and Newborn Genetic Testing Product and Solutions
Table 57. Cepheid Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. EKF Diagnostics Corporate Information, Head Office, and Major Competitors
Table 59. EKF Diagnostics Major Business
Table 60. EKF Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
Table 61. EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Natera Corporate Information, Head Office, and Major Competitors
Table 63. Natera Major Business
Table 64. Natera Prenatal and Newborn Genetic Testing Product and Solutions
Table 65. Natera Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 67. Agilent Technologies Major Business
Table 68. Agilent Technologies Prenatal and Newborn Genetic Testing Product and Solutions
Table 69. Agilent Technologies Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Illumina Corporate Information, Head Office, and Major Competitors
Table 71. Illumina Major Business
Table 72. Illumina Prenatal and Newborn Genetic Testing Product and Solutions
Table 73. Illumina Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Ariosa Diagnostics Corporate Information, Head Office, and Major Competitors
Table 75. Ariosa Diagnostics Major Business
Table 76. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
Table 77. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Sequenom Corporate Information, Head Office, and Major Competitors
Table 79. Sequenom Major Business
Table 80. Sequenom Prenatal and Newborn Genetic Testing Product and Solutions
Table 81. Sequenom Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Prenatal and Newborn Genetic Testing Revenue (USD Million) by Players (2019-2021)
Table 83. Global Prenatal and Newborn Genetic Testing Revenue Share by Players (2019-2021)
Table 84. Breakdown of Prenatal and Newborn Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Prenatal and Newborn Genetic Testing Players Head Office, Products and Services Provided
Table 86. Prenatal and Newborn Genetic Testing Mergers & Acquisitions in the Past Five Years
Table 87. Prenatal and Newborn Genetic Testing New Entrants and Expansion Plans
Table 88. Global Prenatal and Newborn Genetic Testing Revenue (USD Million) by Type (2016-2021)
Table 89. Global Prenatal and Newborn Genetic Testing Revenue Share by Type (2016-2021)
Table 90. Global Prenatal and Newborn Genetic Testing Revenue Forecast by Type (2021-2026)
Table 91. Global Prenatal and Newborn Genetic Testing Revenue by Application (2016-2021)
Table 92. Global Prenatal and Newborn Genetic Testing Revenue Forecast by Application (2021-2026)
Table 93. North America Prenatal and Newborn Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Prenatal and Newborn Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Prenatal and Newborn Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Prenatal and Newborn Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Prenatal and Newborn Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Prenatal and Newborn Genetic Testing Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Prenatal and Newborn Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Prenatal and Newborn Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Prenatal and Newborn Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Prenatal and Newborn Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Prenatal and Newborn Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Prenatal and Newborn Genetic Testing Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Prenatal and Newborn Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Prenatal and Newborn Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Prenatal and Newborn Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Prenatal and Newborn Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Prenatal and Newborn Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Prenatal and Newborn Genetic Testing Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prenatal and Newborn Genetic Testing Picture
Figure 2. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type in 2020
Figure 3. Array-Comparative Genetic Hybridization (aCGH)
Figure 4. Fluorescence In-Situ Hybridization (FISH)
Figure 5. Polymerase Chain Reaction (PCR)
Figure 6. Prenatal and Newborn Genetic Testing Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Diagnostic Organization Picture
Figure 9. Other Picture
Figure 10. Global Prenatal and Newborn Genetic Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Prenatal and Newborn Genetic Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Region (2016-2026)
Figure 13. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Region in 2020
Figure 14. North America Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Prenatal and Newborn Genetic Testing Market Drivers
Figure 19. Prenatal and Newborn Genetic Testing Market Restraints
Figure 20. Prenatal and Newborn Genetic Testing Market Trends
Figure 21. Roche Diagnostic Recent Developments and Future Plans
Figure 22. Elitech Group Recent Developments and Future Plans
Figure 23. Myriad Genetics Recent Developments and Future Plans
Figure 24. Biocartis Recent Developments and Future Plans
Figure 25. IntegraGen Recent Developments and Future Plans
Figure 26. Perkin Elmer Recent Developments and Future Plans
Figure 27. WaferGen Biosystem Recent Developments and Future Plans
Figure 28. Interpace Diagnostics Recent Developments and Future Plans
Figure 29. Quest Diagnostic Recent Developments and Future Plans
Figure 30. Bio-Rad Recent Developments and Future Plans
Figure 31. AutoGenomics Recent Developments and Future Plans
Figure 32. Abbott Recent Developments and Future Plans
Figure 33. Cepheid Recent Developments and Future Plans
Figure 34. EKF Diagnostics Recent Developments and Future Plans
Figure 35. Natera Recent Developments and Future Plans
Figure 36. Agilent Technologies Recent Developments and Future Plans
Figure 37. Illumina Recent Developments and Future Plans
Figure 38. Ariosa Diagnostics Recent Developments and Future Plans
Figure 39. Sequenom Recent Developments and Future Plans
Figure 41. Global Prenatal and Newborn Genetic Testing Revenue Share by Players in 2020
Figure 42. Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Prenatal and Newborn Genetic Testing Revenue Market Share in 2020
Figure 44. Global Top 10 Players Prenatal and Newborn Genetic Testing Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Prenatal and Newborn Genetic Testing Revenue Share by Type in 2020
Figure 47. Global Prenatal and Newborn Genetic Testing Market Share Forecast by Type (2021-2026)
Figure 48. Global Prenatal and Newborn Genetic Testing Revenue Share by Application in 2020
Figure 49. Global Prenatal and Newborn Genetic Testing Market Share Forecast by Application (2021-2026)
Figure 50. North America Prenatal and Newborn Genetic Testing Sales Market Share by Type (2016-2026)
Figure 51. North America Prenatal and Newborn Genetic Testing Sales Market Share by Application (2016-2026)
Figure 52. North America Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 53. United States Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Prenatal and Newborn Genetic Testing Sales Market Share by Type (2016-2026)
Figure 57. Europe Prenatal and Newborn Genetic Testing Sales Market Share by Application (2016-2026)
Figure 58. Europe Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 59. Germany Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Prenatal and Newborn Genetic Testing Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Prenatal and Newborn Genetic Testing Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue Market Share by Region (2016-2026)
Figure 67. China Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Prenatal and Newborn Genetic Testing Sales Market Share by Type (2016-2026)
Figure 74. South America Prenatal and Newborn Genetic Testing Sales Market Share by Application (2016-2026)
Figure 75. South America Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Prenatal and Newborn Genetic Testing Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Prenatal and Newborn Genetic Testing Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界の出生前＆新生児遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal and Newborn Genetic Testing Market The global Prenatal and Newborn Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…- 世界の出生前＆新生児遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal and Newborn Genetic Testing Market The global Prenatal and Newborn Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の出生前遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の遺伝子検査市場規模・現状・予測（2021年-2027年） Genetic testing, also known as DNA testing, allows the determination of bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. In agriculture, a form of genetic testing known as progeny testing can be used to evaluate the quality of breeding stock. In population ecology, gene…
- 世界の遺伝子検査サービス市場規模・現状・予測（2021年-2027年） Genetic test is a type of medical test which analyzes the changes in chromosomes, proteins, or genes, which may be caused by any suspected genetic condition or disease. Market Analysis and Insights: Global Genetic Testing Services Market The global Genetic Testing Services market size is projected t…